Difference between revisions of "Foreign bribery and FCPA violations"

Line 105: Line 105:
|-
|-
|Novartis
|Novartis
|$346 million
|[https://www.sec.gov/news/press-release/2020-144 $346 million]
|
|On June 25, 2020, pharmaceutical company Novartis agreed to pay $346 million to settle SEC and DOJ charges that the company violated the FCPA. According to the SEC’s press release announcing the settlement, between 2012 and 2016 “Novartis or its former subsidiary Alcon Inc. engaged in schemes to make improper payments or to provide benefits to public and private healthcare providers in South Korea, Vietnam, and Greece in exchange for prescribing or using Novartis or Alcon products.”
|-
|-
|Technip
|Technip